The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nalbuphine HCL-Global Market Insights and Sales Trends 2025
Synopsis
Nalbuphine HCL (Nalbuphine hydrochloride) is a narcotic pain reliever used to treat moderate to severe pain.Nubain is also used for treating pain just after surgery or childbirth.
The global Nalbuphine HCL market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nalbuphine HCL in various end use industries. The expanding demands from the Hospital, Pharmacy and Others,, are propelling Nalbuphine HCL market. Adult, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Children segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nalbuphine HCL market, driven by demand from China, the second largest economy with some signs of stabilising, the Nalbuphine HCL market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nalbuphine HCL, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nalbuphine HCL market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nalbuphine HCL market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nalbuphine HCL sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nalbuphine HCL covered in this report include Acme, Dr Reddy's, Glenmark, Global Pharmaceuticals, HOSPIRA, Humanwell, Incepta Pharmaceuticals, Manusaktteva and Opsonin, etc.
The global Nalbuphine HCL market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Acme
Dr Reddy's
Glenmark
Global Pharmaceuticals
HOSPIRA
Humanwell
Incepta Pharmaceuticals
Manusaktteva
Opsonin
Sami
Squarepharma
Global Nalbuphine HCL market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nalbuphine HCL market, Segment by Type:
Adult
Children
Global Nalbuphine HCL market, by Application
Hospital
Pharmacy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nalbuphine HCL manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nalbuphine HCL in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Nalbuphine HCL (Nalbuphine hydrochloride) is a narcotic pain reliever used to treat moderate to severe pain.Nubain is also used for treating pain just after surgery or childbirth.
The global Nalbuphine HCL market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nalbuphine HCL in various end use industries. The expanding demands from the Hospital, Pharmacy and Others,, are propelling Nalbuphine HCL market. Adult, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Children segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nalbuphine HCL market, driven by demand from China, the second largest economy with some signs of stabilising, the Nalbuphine HCL market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nalbuphine HCL, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nalbuphine HCL market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nalbuphine HCL market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nalbuphine HCL sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nalbuphine HCL covered in this report include Acme, Dr Reddy's, Glenmark, Global Pharmaceuticals, HOSPIRA, Humanwell, Incepta Pharmaceuticals, Manusaktteva and Opsonin, etc.
The global Nalbuphine HCL market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Acme
Dr Reddy's
Glenmark
Global Pharmaceuticals
HOSPIRA
Humanwell
Incepta Pharmaceuticals
Manusaktteva
Opsonin
Sami
Squarepharma
Global Nalbuphine HCL market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nalbuphine HCL market, Segment by Type:
Adult
Children
Global Nalbuphine HCL market, by Application
Hospital
Pharmacy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nalbuphine HCL manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nalbuphine HCL in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Nalbuphine HCL Market Overview
1.1 Nalbuphine HCL Product Overview
1.2 Nalbuphine HCL Market Segment by Type
1.2.1 Adult
1.2.2 Children
1.3 Global Nalbuphine HCL Market Size by Type
1.3.1 Global Nalbuphine HCL Market Size Overview by Type (2018-2029)
1.3.2 Global Nalbuphine HCL Historic Market Size Review by Type (2018-2023)
1.3.3 Global Nalbuphine HCL Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nalbuphine HCL Sales Breakdown by Type (2018-2023)
1.4.2 Europe Nalbuphine HCL Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Nalbuphine HCL Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Nalbuphine HCL Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Nalbuphine HCL Sales Breakdown by Type (2018-2023)
2 Global Nalbuphine HCL Market Competition by Company
2.1 Global Top Players by Nalbuphine HCL Sales (2018-2023)
2.2 Global Top Players by Nalbuphine HCL Revenue (2018-2023)
2.3 Global Top Players by Nalbuphine HCL Price (2018-2023)
2.4 Global Top Manufacturers Nalbuphine HCL Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nalbuphine HCL Market Competitive Situation and Trends
2.5.1 Nalbuphine HCL Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Nalbuphine HCL Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nalbuphine HCL as of 2022)
2.7 Date of Key Manufacturers Enter into Nalbuphine HCL Market
2.8 Key Manufacturers Nalbuphine HCL Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nalbuphine HCL Status and Outlook by Region
3.1 Global Nalbuphine HCL Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Nalbuphine HCL Historic Market Size by Region
3.2.1 Global Nalbuphine HCL Sales in Volume by Region (2018-2023)
3.2.2 Global Nalbuphine HCL Sales in Value by Region (2018-2023)
3.2.3 Global Nalbuphine HCL Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Nalbuphine HCL Forecasted Market Size by Region
3.3.1 Global Nalbuphine HCL Sales in Volume by Region (2024-2029)
3.3.2 Global Nalbuphine HCL Sales in Value by Region (2024-2029)
3.3.3 Global Nalbuphine HCL Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Nalbuphine HCL by Application
4.1 Nalbuphine HCL Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Others
4.2 Global Nalbuphine HCL Market Size by Application
4.2.1 Global Nalbuphine HCL Market Size Overview by Application (2018-2029)
4.2.2 Global Nalbuphine HCL Historic Market Size Review by Application (2018-2023)
4.2.3 Global Nalbuphine HCL Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nalbuphine HCL Sales Breakdown by Application (2018-2023)
4.3.2 Europe Nalbuphine HCL Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Nalbuphine HCL Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Nalbuphine HCL Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Nalbuphine HCL Sales Breakdown by Application (2018-2023)
5 North America Nalbuphine HCL by Country
5.1 North America Nalbuphine HCL Historic Market Size by Country
5.1.1 North America Nalbuphine HCL Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Nalbuphine HCL Sales in Volume by Country (2018-2023)
5.1.3 North America Nalbuphine HCL Sales in Value by Country (2018-2023)
5.2 North America Nalbuphine HCL Forecasted Market Size by Country
5.2.1 North America Nalbuphine HCL Sales in Volume by Country (2024-2029)
5.2.2 North America Nalbuphine HCL Sales in Value by Country (2024-2029)
6 Europe Nalbuphine HCL by Country
6.1 Europe Nalbuphine HCL Historic Market Size by Country
6.1.1 Europe Nalbuphine HCL Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Nalbuphine HCL Sales in Volume by Country (2018-2023)
6.1.3 Europe Nalbuphine HCL Sales in Value by Country (2018-2023)
6.2 Europe Nalbuphine HCL Forecasted Market Size by Country
6.2.1 Europe Nalbuphine HCL Sales in Volume by Country (2024-2029)
6.2.2 Europe Nalbuphine HCL Sales in Value by Country (2024-2029)
7 Asia-Pacific Nalbuphine HCL by Region
7.1 Asia-Pacific Nalbuphine HCL Historic Market Size by Region
7.1.1 Asia-Pacific Nalbuphine HCL Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Nalbuphine HCL Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Nalbuphine HCL Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Nalbuphine HCL Forecasted Market Size by Region
7.2.1 Asia-Pacific Nalbuphine HCL Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Nalbuphine HCL Sales in Value by Region (2024-2029)
8 Latin America Nalbuphine HCL by Country
8.1 Latin America Nalbuphine HCL Historic Market Size by Country
8.1.1 Latin America Nalbuphine HCL Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Nalbuphine HCL Sales in Volume by Country (2018-2023)
8.1.3 Latin America Nalbuphine HCL Sales in Value by Country (2018-2023)
8.2 Latin America Nalbuphine HCL Forecasted Market Size by Country
8.2.1 Latin America Nalbuphine HCL Sales in Volume by Country (2024-2029)
8.2.2 Latin America Nalbuphine HCL Sales in Value by Country (2024-2029)
9 Middle East and Africa Nalbuphine HCL by Country
9.1 Middle East and Africa Nalbuphine HCL Historic Market Size by Country
9.1.1 Middle East and Africa Nalbuphine HCL Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Nalbuphine HCL Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Nalbuphine HCL Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Nalbuphine HCL Forecasted Market Size by Country
9.2.1 Middle East and Africa Nalbuphine HCL Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Nalbuphine HCL Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Acme
10.1.1 Acme Company Information
10.1.2 Acme Introduction and Business Overview
10.1.3 Acme Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Acme Nalbuphine HCL Products Offered
10.1.5 Acme Recent Development
10.2 Dr Reddy's
10.2.1 Dr Reddy's Company Information
10.2.2 Dr Reddy's Introduction and Business Overview
10.2.3 Dr Reddy's Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Dr Reddy's Nalbuphine HCL Products Offered
10.2.5 Dr Reddy's Recent Development
10.3 Glenmark
10.3.1 Glenmark Company Information
10.3.2 Glenmark Introduction and Business Overview
10.3.3 Glenmark Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Glenmark Nalbuphine HCL Products Offered
10.3.5 Glenmark Recent Development
10.4 Global Pharmaceuticals
10.4.1 Global Pharmaceuticals Company Information
10.4.2 Global Pharmaceuticals Introduction and Business Overview
10.4.3 Global Pharmaceuticals Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Global Pharmaceuticals Nalbuphine HCL Products Offered
10.4.5 Global Pharmaceuticals Recent Development
10.5 HOSPIRA
10.5.1 HOSPIRA Company Information
10.5.2 HOSPIRA Introduction and Business Overview
10.5.3 HOSPIRA Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.5.4 HOSPIRA Nalbuphine HCL Products Offered
10.5.5 HOSPIRA Recent Development
10.6 Humanwell
10.6.1 Humanwell Company Information
10.6.2 Humanwell Introduction and Business Overview
10.6.3 Humanwell Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Humanwell Nalbuphine HCL Products Offered
10.6.5 Humanwell Recent Development
10.7 Incepta Pharmaceuticals
10.7.1 Incepta Pharmaceuticals Company Information
10.7.2 Incepta Pharmaceuticals Introduction and Business Overview
10.7.3 Incepta Pharmaceuticals Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Incepta Pharmaceuticals Nalbuphine HCL Products Offered
10.7.5 Incepta Pharmaceuticals Recent Development
10.8 Manusaktteva
10.8.1 Manusaktteva Company Information
10.8.2 Manusaktteva Introduction and Business Overview
10.8.3 Manusaktteva Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Manusaktteva Nalbuphine HCL Products Offered
10.8.5 Manusaktteva Recent Development
10.9 Opsonin
10.9.1 Opsonin Company Information
10.9.2 Opsonin Introduction and Business Overview
10.9.3 Opsonin Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Opsonin Nalbuphine HCL Products Offered
10.9.5 Opsonin Recent Development
10.10 Sami
10.10.1 Sami Company Information
10.10.2 Sami Introduction and Business Overview
10.10.3 Sami Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sami Nalbuphine HCL Products Offered
10.10.5 Sami Recent Development
10.11 Squarepharma
10.11.1 Squarepharma Company Information
10.11.2 Squarepharma Introduction and Business Overview
10.11.3 Squarepharma Nalbuphine HCL Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Squarepharma Nalbuphine HCL Products Offered
10.11.5 Squarepharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nalbuphine HCL Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nalbuphine HCL Industrial Chain Analysis
11.4 Nalbuphine HCL Market Dynamics
11.4.1 Nalbuphine HCL Industry Trends
11.4.2 Nalbuphine HCL Market Drivers
11.4.3 Nalbuphine HCL Market Challenges
11.4.4 Nalbuphine HCL Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nalbuphine HCL Distributors
12.3 Nalbuphine HCL Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
